TRANSLATE BIO Trademark

Trademark Overview

On Thursday, March 25, 2021, a trademark application was filed for TRANSLATE BIO with the United States Patent and Trademark Office. The USPTO has given the TRANSLATE BIO trademark a serial number of 90602577. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, August 20, 2024. This trademark is owned by Translate Bio, Inc.. The TRANSLATE BIO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders...
translate bio

General Information

Serial Number90602577
Word MarkTRANSLATE BIO
Filing DateThursday, March 25, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, August 20, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 14, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; medicines for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biotherapeutics, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; biosimilars, namely, biological preparations for the treatment of rare or orphan diseases, pulmonary disorders, metabolic disorders, hepatic disorders, cancers, neurological disorders, ocular disorders, neuromuscular disorders, cardiovascular disorders, cardiac disorders, inflammatory disorders, immunoregulatory disorders, infectious disorders, and reproductive disorders; therapeutic and prophylactic vaccines
NOT AVAILABLE"BIO"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 30, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTranslate Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameTranslate Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421

Trademark Events

Event DateEvent Description
Monday, March 29, 2021NEW APPLICATION ENTERED
Monday, May 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 10, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 10, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, June 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, June 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, November 16, 2021NON-FINAL ACTION E-MAILED
Wednesday, June 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 2, 2021ASSIGNED TO EXAMINER
Tuesday, November 16, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 16, 2021NON-FINAL ACTION WRITTEN
Thursday, May 12, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, January 5, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 5, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 5, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 12, 2022EXAMINERS AMENDMENT -WRITTEN
Thursday, May 12, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, May 12, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, May 12, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2022PUBLISHED FOR OPPOSITION
Tuesday, October 4, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 14, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, July 8, 2022EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, August 24, 2022EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Friday, March 31, 2023SOU EXTENSION 1 FILED
Monday, October 17, 2022ASSIGNED TO EXAMINER
Friday, March 31, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023SOU EXTENSION 1 GRANTED
Tuesday, September 26, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 26, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 17, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 26, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 26, 2023TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Monday, October 2, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 2, 2023SOU EXTENSION 2 FILED
Monday, October 2, 2023SOU EXTENSION 2 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, November 17, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 1, 2024SOU EXTENSION 3 GRANTED
Friday, March 1, 2024SOU EXTENSION 3 FILED
Friday, March 1, 2024SOU TEAS EXTENSION RECEIVED
Saturday, March 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU TEAS EXTENSION RECEIVED
Friday, February 14, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, August 20, 2024SOU EXTENSION 4 GRANTED
Tuesday, August 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2024SOU EXTENSION 4 FILED

Related Keywords

translate disorders ocular neurological neuromuscular cardiovascular immunoregulatory inflammatory cardiac hepatic cancers